News

The European CMT Federation is proud to highlight the publication of a definitive new review in Nature Reviews Disease Primers. Authored by world-leading experts—including key members of the European CMT Research Association (ECRA) Board—this document sets the standard for our understanding of CMT for the next decade.

This comprehensive update moves beyond traditional knowledge, offering critical insights into:

Global Epidemiology: Revised prevalence data revealing significant geographic variability and underdiagnosis.

Diagnostic Innovation: The shift toward Long-read Whole Genome Sequencing to uncover complex genetic causes.

Therapeutic Pipeline: A promising transition from symptomatic management to disease-modifying therapies currently in clinical trials.

This publication explicitly acknowledges the vital role of Europäische CMT Forschungsgesellschaft (European CMT Research Association, ECRA) e.V., cementing the link between patient advocacy and scientific excellence.

Read our full summary and analysis of this milestone publication here: https://lnkd.in/dpekxq3i